Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-000701
Filing Date
2022-01-14
Accepted
2022-01-14 12:02:48
Documents
1
Period of Report
2022-01-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-55052.html 4  
1 PRIMARY DOCUMENT marketforms-55052.xml 4 6344
  Complete submission text file 0001214659-22-000701.txt   7737
Mailing Address UCLA SCHOOL OF MEDICINE 10833 LE CONTE 66-118 CHS BOX 951738 LOS ANGELES CA 9095-1738
Business Address
Belldegrun Arie (Reporting) CIK: 0001296549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 22530995

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)